Glaukos (GKOS) vs Teleflex (TFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Glaukos (GKOS) has outperformed Teleflex (TFX) over the past year, gaining 84.1% versus a loss of 3.3%. Over five years, GKOS leads with a +259.9% price change compared with -65.8% for TFX. Glaukos is the larger company by market cap ($9.51 billion vs $5.26 billion), about 1.8 times the size.
On valuation, Teleflex trades at a lower forward P/E (11.3x vs 308.1x for Glaukos). Teleflex pays a dividend yielding 1.10%, while Glaukos does not currently pay one. Glaukos converts more of its revenue into profit, with a net margin of -37.0% versus -45.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GKOS | TFX |
|---|---|---|
| Share price | $161.29 | $124.19 |
| Market cap | $9.51B | $5.26B |
| 1-day change | -6.32% | -0.23% |
| YTD return | +42.85% | +1.76% |
| 1-year return | +84.14% | -3.30% |
| 5-year return | +259.86% | -65.81% |
| Forward P/E | 308.06 | 11.34 |
| EPS (TTM) | $-3.26 | $-8.48 |
| Dividend yield | 0.00% | 1.10% |
| Annual dividend | $0.00 | $1.36 |
| Revenue (latest FY) | $507.44M | $1.99B |
| Revenue growth (YoY) | +32.33% | +17.25% |
| Net income (latest FY) | $-187.69M | $-905.64M |
| Gross margin | 55.72% | 56.24% |
| Operating margin | -39.33% | 5.94% |
| Net margin | -36.99% | -45.45% |
| 52-week high | $191.62 | $145.00 |
| 52-week low | $73.16 | $100.18 |
| Distance from 52-week high | -15.83% | -14.35% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +23.19% | +24.59% |
| Average volume | 831.71K | 662.34K |
| Shares outstanding | 58.98M | 42.37M |
| Employees | 1,094 | 15,500 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GKOS has outperformed TFX by 87.4 percentage points over the past year.
- Teleflex offers a meaningfully higher dividend yield (1.10% vs 0.00%).
- Glaukos is more profitable, keeping -37.0 cents of every revenue dollar as net income versus -45.4 cents for Teleflex.
- Glaukos grew revenue faster in its latest fiscal year (+32.33% vs +17.25%).
- The two companies sit in different sectors: Glaukos in Healthcare and Teleflex in Health Care.
About Glaukos
GKOS stock →Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.
Healthcare · Medical Devices · 1,094 employees
About Teleflex
TFX stock →Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
Health Care · Medical/Dental Instruments · 15,500 employees
GKOS vs TFX FAQ
Which is bigger, Glaukos or Teleflex?
Glaukos (GKOS) is larger, with a market capitalization of $9.51B compared with $5.26B for Teleflex (TFX).
Which stock has performed better over the past year, GKOS or TFX?
GKOS returned +84.14% over the past 12 months, compared with -3.30% for TFX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Glaukos or Teleflex?
Teleflex pays a dividend yielding 1.10%, while Glaukos does not currently pay a regular dividend.
Are Glaukos and Teleflex in the same industry?
No. Glaukos is in the Healthcare sector, while Teleflex is in Health Care.